The epidemiology of transfusion: where blood goes and why we should care about it
Sign Up to like & getrecommendations! Published in 2017 at "Transfusion"
DOI: 10.1111/trf.14385
Abstract: B lood transfusion is one of the most commonly performed clinical procedures. The provision of blood for transfusion at the patient’s bedside is dependent on a complex series of events starting with recruitment of blood… read more here.
Keywords: supply; transfusion; epidemiology; blood ... See more keywords
Use of Bypassing Agents and Risk of Thromboembolic Events in Patients with Haemophilia and Inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "Thrombosis and haemostasis"
DOI: 10.1160/th17-05-0365
Abstract: Patients with haemophilia and inhibitors to factors VIII or IX require bypassing therapy. The primary safety concern of bypassing agents is thromboembolism; however, the incidence of thromboembolic adverse events (TAEs) in haemophilia patients with inhibitors… read more here.
Keywords: use bypassing; patients haemophilia; haemophilia inhibitors; events per ... See more keywords
Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2022 at "Upsala Journal of Medical Sciences"
DOI: 10.48101/ujms.v127.8167
Abstract: Background Corticosteroids, immunomodulators (IM) and tumour necrosis factor antagonists (anti-TNF) are commonly used in the treatment of inflammatory bowel disease (IBD) but they also supress the defence against infectious disease. The aim of this study… read more here.
Keywords: 100 person; per 100; disease; person years ... See more keywords